Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-025014
Filing Date
2024-08-07
Accepted
2024-08-07 07:00:54
Documents
87
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clnn20240630_10q.htm   iXBRL 10-Q 1949202
2 EXHIBIT 31.1 ex_678263.htm EX-31.1 12746
3 EXHIBIT 31.2 ex_678264.htm EX-31.2 12511
4 EXHIBIT 32.1 ex_678265.htm EX-32.1 6093
5 EXHIBIT 32.2 ex_678266.htm EX-32.2 6026
11 pipelinejuly202424pct.jpg GRAPHIC 107711
  Complete submission text file 0001437749-24-025014.txt   10319179

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA clnn-20240630.xsd EX-101.SCH 92069
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clnn-20240630_cal.xml EX-101.CAL 61242
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20240630_def.xml EX-101.DEF 558871
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20240630_lab.xml EX-101.LAB 535241
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20240630_pre.xml EX-101.PRE 600700
90 EXTRACTED XBRL INSTANCE DOCUMENT clnn20240630_10q_htm.xml XML 1879861
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39834 | Film No.: 241181368
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)